Filing Details

Accession Number:
0001408498-14-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-19 14:15:51
Reporting Period:
2014-08-18
Filing Date:
2014-08-19
Accepted Time:
2014-08-19 14:15:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400482 Acucela Inc. M?????? Pharmaceutical Preparations (2834) 020592619
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408498 L David Lowrance C/O Acucela Inc.
1301 Second Ave., Suite 1900
Seattle WA 98101
Cfo, Secretary, Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-18 40,500 $4.52 40,500 No 4 M Direct
Common Stock Disposition 2014-08-18 40,500 $7.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-08-18 40,500 $4.52 40,500 $4.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,000 2021-05-17 No 4 M Direct
Footnotes
  1. The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-1929000).
  2. The shares were sold at a price of 729 Japanese Yen. The U.S. per share price reflects the average of the buy and sell Japanese Yen-to-U.S. Dollar exchange rates on the transaction date divided by the number of shares sold.
  3. The option vests and is exercisable at the rate of 1/5th of the total shares on April 23, 2012 and then an additional 1/5th yearly thereafter, with 100% vested and exercisable on April 23, 2016, subject to the reporting person's provision of service to the issuer on each vesting date.